An Exploratory Assessment of Pre-Treatment Inflammatory Profiles in Gastric Cancer Patients.

Gastric cancer ranks as the fifth most common cancer, and the assessment of inflammatory biomarkers in these patients holds significant promise in predicting prognosis. Therefore, data from patients undergoing surgical intervention for gastric cancer over a 7-year period were analyzed. This study was retrospective and involved a preoperative investigation of six inflammatory parameters derived from complete blood counts. Statistical analysis revealed a significant increase in the leucocyte-to-monocyte ratio (LMR) ( p = 0.048), along with a significant decrease in the number of lymphocytes and monocytes compared to patients with successful discharge. Taking into consideration patients undergoing emergency surgery, a significant increase in the LMR ( p = 0.009), neutrophil-to-lymphocyte ratio (NLR) ( p = 0.004), Aggregate Index of Systemic Inflammation (AISI) ( p = 0.01), and Systemic Immune-Inflammation Index (SII) ( p = 0.028) was observed. Regarding relapse, these patients exhibited significant increases in AISI ( p = 0.032) and SII ( p = 0.047). Inflammatory biomarkers represent a valuable tool in evaluating and predicting the prognosis of patients with gastric cancer.